APS and the brain (Q33196667)

23 July 2017

1 reference

title

APS and the brain (English)

1 reference

23 July 2017

J Sastre-Garriga

1

1 reference

23 July 2017

X Montalban

series ordinal

2

1 reference

23 July 2017

publication date

1 January 2003

1 reference

23 July 2017

1 reference

23 July 2017

volume

12

1 reference

23 July 2017

issue

12

1 reference

23 July 2017

page(s)

877-882

1 reference

Antiphospholipid antibodies: a critique of their heterogeneity and hegemony

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Neuropsychiatric syndromes in lupus: prevalence using standardized definitions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Antiphospholipid antibodies in cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Antiphospholipid antibodies in the acute phase of cerebral ischaemia in young adults: a descriptive study of 139 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Anticardiolipin antibodies are not an independent risk factor for stroke: an incident case-referent study nested within the MONICA and Västerbotten cohort project

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Valvular heart disease in the primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

beta 2-Glycoprotein I: target antigen for autoantibodies in the 'antiphospholipid syndrome'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Accelerated atheroma and anti-beta2-glycoprotein I antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Cerebral venous thrombosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Traumatic intracerebral venous thrombosis associated with an abnormal golf swing

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Transient monocular blindness and antiphospholipid antibodies in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Anti-cardiolipin and anti-beta2 glycoprotein I antibodies in Indian patients with systemic lupus erythematosus: association with the presence of seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Lupus anticoagulant and late onset seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Headache in systemic lupus erythematosus: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Chronic or recurrent headache in patients with systemic lupus erythematosus: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

The association between the antiphospholipid antibody syndrome and neuropsychological impairment in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Anticardiolipin antibodies in normal subjects. Neuropsychological correlates and MRI findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Transverse myelopathy in SLE: clinical features and functional outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Anterior spinal artery syndrome in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Proposed diagnostic criteria and nosology of acute transverse myelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

The clinical course of neuromyelitis optica (Devic's syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Optic neuropathy in systemic lupus erythematosus and antiphospholipid syndrome (APS): clinical features, pathogenesis, review of the literature and proposed ophthalmological criteria for APS diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Anticardiolipin antibodies in patients with multiple sclerosis do not represent a subgroup of patients according to clinical, familial, and biological characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Oculomotor palsy in six patients with systemic lupus erythematosus. A possible role of antiphospholipid syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

CNS lupus--where do we go from here?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Antiphospholipid antibodies do not a syndrome make

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

Anticardiolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU496OA

10.1191/0961203303LU496OA

21 January 2018

Identifiers

DOI

1 reference

23 July 2017

1 reference